HomeAMBS • OTCMKTS
add
Amarantus Bioscience Holdings Inc
Previous close
$0.00
Market cap
630.00 USD
Avg Volume
502.00
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2018info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.04M | -6.84% |
Net income | -10.58M | -128.49% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2018info | Y/Y change |
|---|---|---|
Cash and short-term investments | 829.00 | -98.39% |
Total assets | 3.48M | -66.00% |
Total liabilities | 31.39M | 10.61% |
Total equity | -27.90M | — |
Shares outstanding | 234.16M | — |
Price to book | -0.00 | — |
Return on assets | -27.69% | — |
Return on capital | 22.85% | — |
Cash Flow
Net change in cash
| (USD) | 2018info | Y/Y change |
|---|---|---|
Net income | -10.58M | -128.49% |
Cash from operations | -1.80M | -107.82% |
Cash from investing | 6.07M | 35,108.16% |
Cash from financing | -4.33M | -609.62% |
Net change in cash | -50.52K | -2,473.09% |
Free cash flow | -6.75M | — |
About
Founded
2008
Headquarters
Website
Employees
12
